CytomX Therapeutics (CTMX) Current Deferred Revenue (2014 - 2026)
CytomX Therapeutics' Current Deferred Revenue was $24.07 million in Q2 2026, up 9.2% from $22.05 million a year earlier and up 34.7% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Current Deferred Revenue (2014 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at CytomX Therapeutics came in at $26.88 million, down 60.0% from FY2024.
- Current Deferred Revenue shows a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $67.2 million in FY2024 (-49.2%), $132.27 million in FY2023 (+9.1%), $121.27 million in FY2022 (+197.1%) and $40.82 million in FY2021 (-2.9%).
- Quarterly Current Deferred Revenue has moved between $17.88 million (Q1 2026) and $132.27 million (Q4 2023) over five years.
- Compared with a year earlier, Current Deferred Revenue was higher in 1 of the last eight quarters, with an average decline of 50.1%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q4 2022 (growth of 197.1%); the worst was Q2 2025 (a decline of 82.2%).
- Per Business Quant data, CTMX's Current Deferred Revenue in the three quarters before Q2 2026 was $17.88 million (Q1 2026), $26.88 million (Q4 2025) and $22.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | CytomX Therapeutics | 599.22 Mn | -358.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.07 Mn |
| Mar 31, 2026 | 17.88 Mn |
| Dec 31, 2025 | 26.88 Mn |
| Sep 30, 2025 | 22.38 Mn |
| Jun 30, 2025 | 22.05 Mn |
| Mar 31, 2025 | 33.23 Mn |
| Dec 31, 2024 | 67.20 Mn |
| Sep 30, 2024 | 96.06 Mn |
| Jun 30, 2024 | 123.77 Mn |
| Mar 31, 2024 | 123.63 Mn |
| Dec 31, 2023 | 132.27 Mn |
| Sep 30, 2023 | 124.40 Mn |
| Jun 30, 2023 | 120.28 Mn |
| Mar 31, 2023 | 126.78 Mn |
| Dec 31, 2022 | 121.27 Mn |
| Sep 30, 2022 | 87.13 Mn |
| Jun 30, 2022 | 60.99 Mn |
| Mar 31, 2022 | 54.65 Mn |
| Dec 31, 2021 | 40.82 Mn |
| Sep 30, 2021 | 40.84 Mn |
API Access
CytomX Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();